RA
BFRI icon

Rosalind Advisors’s Biofrontera BFRI Stock Holding History

Rosalind Advisors’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$942K Buy
1,163,962
+23,198
+2% +$20K 0.38% 33
2025
Q4 		$650K Hold
1,140,764
– – 0.23% 34
2025
Q3 		$1.12M Buy
1,140,764
+164,316
+17% +$149K 0.38% 28
2025
Q2 		$695K Buy
976,448
+332,055
+52% +$232K 0.33% 28
2025
Q1 		$516K Sell
644,393
-167,525
-21% -$172K 0.25% 31
2024
Q4 		$885K Buy
811,918
+316,428
+64% +$299K 0.45% 27
2024
Q3 		$659K Sell
495,490
-8,771
-2% -$10K 0.42% 26
2024
Q2 		$453K Hold
504,261
– – 0.35% 34
2024
Q1 		$777K Buy
+504,261
New +$699K 0.73% 28

Other funds holding BFRI

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rosalind Advisors's BFRI Position: Q1 2026 in Review

Rosalind Advisors increased its Biofrontera (BFRI) stake by 2% in Q1 2026, buying an estimated $20K and bringing the position to 1,163,962 shares worth $942K. The position accounts for 0.38% of the portfolio, ranked #33.

Rosalind Advisors first reported a position in BFRI in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.12M in Q3 2025. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Rosalind Advisors held 1,163,962 shares of Biofrontera worth $942K as of Q1 2026.
  • Rosalind Advisors bought 23,198 Biofrontera shares in Q1 2026, an estimated $20K.
  • Biofrontera made up 0.38% of Rosalind Advisors's portfolio in Q1 2026, its #33 holding.
  • Rosalind Advisors first reported a position in Biofrontera in Q1 2024 and has held it in 9 quarters since.
  • Rosalind Advisors's Biofrontera position peaked at $1.12M in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Rosalind Advisors's 13F filing for Q1 2026, filed 14 May 2026.